WiseGuyRerports.com Presents “Global In-Vitro Diagnostics (IVDs) Market Insights, Forecast to 2025” New Document to its Studies Database
In-Vitro Diagnostics (IVDs) are the advanced medical accessories and devices utilized to perform tests on blood, urine, and tissue samples that have been taken from the human body, in order to help detect severe infection, Diagnose an adverse medical condition, prevent diseases, and monitor efficient drug therapies. The global in-vitro diagnostics (IVDs) market is expected to prosper at a considerable CAGR during the forecast period. The growing geriatric population, which is susceptible to numerous hazardous diseases and requires regular diagnostic tests and medical treatments, is expected to drive the demand for Vitro Diagnostics during the forecast period.
Furthermore, modern product launch and technological improvements, in terms of system accuracy, cost-effectiveness, and portability, are expected to propel in-vitro diagnostics (IVDs) market growth during the forecast period. Surging prevalence of several deadly diseases, such as autoimmune diseases, inflammatory infections, and cancer is expected to drive the demand for IVD testing and treatments. Increasing demand for advanced Point-of-Care (PoC) devices is anticipated to fuel market growth. In addition, the introduction of advanced technologies, such as nano-biotechnology and biochips, and high-level miniaturization of microfluidics are anticipated to enhance the demand for advanced PoC products.
These advancements have facilitated effortless access to PoC diagnostic tests and are likely to offer timely and effective test results, thereby strengthening the overall market growth. Immunoassay diagnosis is the most crucial segment of the market. Increasing the incidence of communicable and chronic diseases and rising demand for early diagnosis are the main factors driving the immunoassay diagnosis segment. Molecular diagnostics is another crucial market segment that enables the timely detection of infectious diseases, cancer, and genetic disorders by utilizing advanced genetic technologies.
Thermo Fisher Scientific
Johnson and Johnson
Dickinson and Company
The global in-vitro diagnostics (IVDs) market can be analyzed on the basis of major product types, crucial end-users, the prominent market players, and regional markets.
Based on the product types, the global in-vitro diagnostics (IVDs) market can be segmented into-
- Clinical Chemistry
- Molecular Diagnostics
Based on the major end-users, the global in-vitro diagnostics (IVDs) can be segmented into-
- Home Care
The hospital segment is considered crucial, owing to increased demand for efficient IVD tests across the globe. In-vitro diagnostics (IVDs) can be effectively utilized to diagnose infectious disease, cardiological issues, diabetes, cancer, nephrology, autoimmune diseases. IVD can also be used for efficient drug examination.
North America, Asia Pacific, Europe, Central and South America, and the Middle East and Africa are the major regions contributing to the growth and development of the global In-Vitro diagnostic market. North America is considered as the most prominent market for IVD. Supportive government regulations, advanced diagnostic infrastructure, ongoing technological advancements, and the existence of prominent market players are expected to drive the in-vitro diagnostics (IVDs) market in this region. The Asia Pacific is anticipated to observe considerable growth over the forecast period. The existence of the target population base and constantly improving healthcare infrastructure in the Asia Pacific are foreseen to enhance the market growth in this region.
JVCKENWOOD Corp. and Sysmex Corp together have established a new organization, named as Creative Nanosystems Corp, to design, implement, and manufacture high-quality and efficient biodevices. In July 2018, Surmodics, Inc. launched an advanced solution, called MatrixGuard Diluent, to reduce errors and negligence in in-vitro diagnostics (IVDs) tests. In December 2018, Novacyt introduced its modern CE-IVD mark molecular diagnostic equipment, known as Genesig Real-Time PCR BK virus (BKV) Kit and Epstein – Barr virus (EBV) Kit.
Table Of Content:
1 Report Overview
2 Global Growth Trends
3 Market Share by Key Players
4 Breakdown Data by Type and Application
5 United States
9 Southeast Asia
11 Central & South America
12 International Players Profiles
13 Market Forecast 2019-2025
14 Analyst’s Viewpoints/Conclusions
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)